WallStreetZenWallStreetZen

NASDAQ: GERN
Geron Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

GERN past revenue growth

How has GERN's revenue growth performed historically?
Company
7.75%
Industry
944.69%
Market
41.92%
GERN's revenue has grown slower... subscribe to Premium to read more.
Performance
GERN's revenue has grown slower... subscribe to Premium to read more.
Performance
GERN's revenue growth is accelerating... subscribe to Premium to read more.
Performance

GERN earnings and revenue history

Current Revenue
$403.0k
Current Earnings
-$107.9M
Current Profit Margin
-26,769.7%

GERN Return on equity

Current Company
-58.3%
Current Industry
8.9%
Current Market
93.9%
GERN's Return on Equity (-58.3%)... subscribe to Premium to read more.
Performance

GERN Return on assets

Current Company
-42.7%
Current Industry
3%
GERN is generating lower Return... subscribe to Premium to read more.
Performance

GERN Return on capital employed

Current Company
-54.84%
Current Industry
10.9%
GERN's ability to generate Return... subscribe to Premium to read more.
Performance

GERN earnings dates

Next earnings date
Mar 9, 2022

Geron Corp Earnings & Revenue FAQ

What were GERN's earnings last quarter?

On Invalid Date, Geron Corp (NASDAQ: GERN) reported Q3 2021 earnings per share (EPS) of -$0.08, up 33.33% year over year. Total Geron Corp earnings for the quarter were -$26.70 million. In the same quarter last year, Geron Corp's earnings per share (EPS) was -$0.06.

What was GERN's earnings growth in the past year?

As of Q1 2022, Geron Corp's earnings has grown null year over year. Geron Corp's earnings in the past year totalled -$107.88 million.

What is GERN's earnings date?

Geron Corp's earnings date is Invalid Date. Add GERN to your watchlist to be reminded of GERN's next earnings announcement.

What was GERN's revenue last quarter?

On Invalid Date, Geron Corp (NASDAQ: GERN) reported Q3 2021 revenue of $109.00 thousand up 0.93% year over year. In the same quarter last year, Geron Corp's revenue was $108.00 thousand.

What was GERN's revenue growth in the past year?

As of Q1 2022, Geron Corp's revenue has grown 7.75% year over year. This is 936.94 percentage points lower than the US Biotechnology industry revenue growth rate of 944.69%. Geron Corp's revenue in the past year totalled $403.00 thousand.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.